These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11526967)

  • 1. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
    Izzo E; Orsini C; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules.
    Zhang D; Wang X; Xiang X; Chen H; Zhang J; Su Q; Hao W
    Pharmacol Biochem Behav; 2010 Dec; 97(2):222-6. PubMed ID: 20705086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
    McDougall SA; Hernandez RM; Reichel CM; Farley CM
    Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
    Pulvirenti L; Balducci C; Piercy M; Koob GF
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level lead exposure modulates effects of quinpirole and eticlopride on response rates in a fixed-interval schedule.
    Areola OO; Jadhav AL
    Pharmacol Biochem Behav; 2001; 69(1-2):151-6. PubMed ID: 11420080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats.
    Sibole JM; Matea PJ; Krall CM; McDougall SA
    Pharmacol Biochem Behav; 2003 Aug; 76(1):27-34. PubMed ID: 13679214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.
    Chen YC; Choi JK; Andersen SL; Rosen BR; Jenkins BG
    Psychopharmacology (Berl); 2005 Aug; 180(4):705-15. PubMed ID: 15536545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.
    Wacan JJ; Reichel CM; Farley CM; McDougall SA
    Psychopharmacology (Berl); 2006 Mar; 185(1):104-11. PubMed ID: 16447063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors.
    Brockel BJ; Cory-Slechta DA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):423-34. PubMed ID: 10418784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
    Weissenborn R; Deroche V; Koob GF; Weiss F
    Psychopharmacology (Berl); 1996 Aug; 126(4):311-22. PubMed ID: 8878347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement.
    Woolverton WL; Ranaldi R
    Pharmacol Biochem Behav; 2002 Jul; 72(4):803-9. PubMed ID: 12062569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
    Fraioli S; Cioli I; Nencini P
    Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL; Allen JD
    Pharmacol Biochem Behav; 1996 Apr; 53(4):759-64. PubMed ID: 8801575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C; Koob GF; Pulvirenti L
    Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
    Caine SB; Negus SS; Mello NK; Patel S; Bristow L; Kulagowski J; Vallone D; Saiardi A; Borrelli E
    J Neurosci; 2002 Apr; 22(7):2977-88. PubMed ID: 11923462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
    Boulougouris V; Castañé A; Robbins TW
    Psychopharmacology (Berl); 2009 Mar; 202(4):611-20. PubMed ID: 18836703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.